During osteolytic cancer bone metastasis, augmented GLI activity in tumor cells leads to secretion of parathyroid hormone-related protein (PTHrP), which induces the Receptor Activator of Nuclear factor-κB Ligand (RANKL) expression in osteoblasts, thus promoting osteoclastogenesis [22]. Here, PTHLH is linked to cancer.